Recently, Yao et al. demonstrated that plasmatic exosomal levels of PRKACA-202, H19-204, and THEMIS2-211 were upregulated in HCC patients when compared to normal controls [117]. The gene discussed is PRKACA; the disease is hepatocellular carcinoma.